The role of adenovirus 36 as a risk factor in obesity: The first clinical study made in the fatty tissues of adults in Turkey
Yazar
Koksal, Selcuk
Cortuk, Oguz
Ersin, Idris
Richt, Juergen A.
Goossens, Valere J.
Kocak, Banu Tufan
Yilmaz, Huseyin
Dinc, Harika Oyku
Arinci, Atilla
Altan, Eda
Habip, Zafer
Elbey, Huseyin
Sirekbasan, Serhat
Turan, Nuri
Cizmecigil, Utku
Karakullukcu, Asiye
Ergin, Sevgi
Kocazeybek, Bekir
Saribas, Suat
Pilanci, Ozgur
Üst veri
Tüm öğe kaydını gösterÖzet
Obesity which developes due to multifactorial reasons, was associated recently with human Adenovirus-36 (Ad-36). The aim of this study was to investigate the prevalence of Ad-36 antibodies in obese adults and also to investigate the DNA of Ad-36 in their adipose tissue. In this cross-sectional and case-control based study, 49 obese adults, with BMI >= 30 kg/m(2), and 49 non-obese adults, with BMI = 1:8 were accepted as positive. Ad-36 antibody was detected in 6 (12.2%) of 49 patients by SNA and was statistically significant (p 0.05), lower mean serum cholesterol and triglyceride levels were found in the Ad-36-positive patients. In conclusion, we couldn't detect Ad-36 DNA in adipose tissue; however, we detected significantly higher Ad-36 antibody levels in the obese group compared to the non-obese group, according to the both univariant and multivariant analyses, suggesting that Ad-36 may play a role in obesity. There is a need for new and extended serial, particularly cohort and human-based, studies in order to have a clear understanding of the Ad-36-obesity relationship. (C) 2015 Elsevier Ltd. All rights reserved.
Koleksiyonlar
- Makale [92796]